sécurité sociale – Retrait de la liste des molécules dites onéreuses de certains traitements

This written question asks about the criteria and process for removing certain expensive medical treatments from social security coverage lists. It seeks to understand the implications for patients and the healthcare system. The question focuses on the impact of these decisions on access to care for individuals relying on these treatments and the financial sustainability of social security schemes.